Lymphotactin and Interleukin-2 gene-modified neuroblastoma tumor cells

· Baylor College of Medicine

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Lymphotactin and Interleukin-2 gene-modified neuroblastoma tumor cells, covering 2025-07-04 to 2025-07-04. Get the full timeline:

Most recent: Clinical Trial Update: A Phase I/II Study Of Immunization With Lymphotactin And Interleukin 2 Gene Modified Neuroblastoma Tumor Cells [Phase 1, Phase 2]

See pricing